{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:15:44Z","timestamp":1793834144827,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072060 and 82360110"],"award-info":[{"award-number":["82072060 and 82360110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["SWU-XDPY22006 and SWU-KQ22075"],"award-info":[{"award-number":["SWU-XDPY22006 and SWU-KQ22075"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013160","name":"Venture & Innovation Support Program for Chongqing Overseas Returnees","doi-asserted-by":"crossref","award":["2205012980212766"],"award-info":[{"award-number":["2205012980212766"]}],"id":[{"id":"10.13039\/501100013160","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Distinguished Young Scholars of Chongqing","award":["2022NSCQ-JQX5279"],"award-info":[{"award-number":["2022NSCQ-JQX5279"]}]},{"name":"Natural Science Foundation Project of Chongqing","award":["cstc2020jcyj-msxmX0292"],"award-info":[{"award-number":["cstc2020jcyj-msxmX0292"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The clinical application of conventional medications for hepatocellular carcinoma treatment has been severely restricted by their adverse effects and unsatisfactory therapeutic effectiveness. Inspired by the concept of \u2018medicine food homology\u2019, we extracted and purified natural exosome-like lipid nanoparticles (LNPs) from black mulberry (\n                    <jats:italic>Morus nigra<\/jats:italic>\n                    L.) leaves. The obtained MLNPs possessed a desirable hydrodynamic particle size (162.1\u00a0nm), a uniform size distribution (polydispersity index\u2009=\u20090.025), and a negative surface charge (-26.6 mv). These natural LNPs were rich in glycolipids, functional proteins, and active small molecules (e.g., rutin and quercetin 3-\n                    <jats:italic>O<\/jats:italic>\n                    -glucoside). In vitro experiments revealed that MLNPs were preferentially internalized by liver tumor cell lines\n                    <jats:italic>via<\/jats:italic>\n                    galactose receptor-mediated endocytosis, increased intracellular oxidative stress, and triggered mitochondrial damage, resulting in suppressing the viability, migration, and invasion of these cells. Importantly, in vivo investigations suggested that oral MLNPs entered into the circulatory system mainly through the jejunum and colon, and they exhibited negligible adverse effects and superior anti-liver tumor outcomes through direct tumor killing and intestinal microbiota modulation. These findings collectively demonstrate the potential of MLNPs as a natural, safe, and robust nanomedicine for oral treatment of hepatocellular carcinoma.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphic abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-023-02286-3","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T22:02:09Z","timestamp":1704232929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route"],"prefix":"10.1186","volume":"22","author":[{"given":"Qiang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghang","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui L.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhas C.","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"2286_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"2286_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2286_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European association for the study of the liver","year":"2018","unstructured":"European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236.","journal-title":"J Hepatol"},{"key":"2286_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u201314.","journal-title":"Lancet"},{"key":"2286_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"2286_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35\u201343.","journal-title":"Lancet Oncol"},{"key":"2286_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","volume":"154","author":"V Mazzaferro","year":"2018","unstructured":"Mazzaferro V, Sposito C, Zhou J, Pinna AD, De Carlis L, Fan J, et al. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma. Gastroenterology. 2018;154:128\u201339.","journal-title":"Gastroenterology"},{"key":"2286_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/bjs.11451","volume":"107","author":"D Wallace","year":"2020","unstructured":"Wallace D, Cowling TE, Walker K, Suddle A, Rowe I, Callaghan C, et al. Short-and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK. Br J Surg. 2020;107:896\u2013905.","journal-title":"Br J Surg"},{"key":"2286_CR9","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367.","DOI":"10.1126\/science.aau6977"},{"key":"2286_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.addr.2018.06.017","volume":"130","author":"JPK Armstrong","year":"2018","unstructured":"Armstrong JPK, Stevens MM. Strategic design of extracellular vesicle drug delivery systems. Adv Drug Deliv Rev. 2018;130:12\u20136.","journal-title":"Adv Drug Deliv Rev"},{"key":"2286_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2018.01.022","volume":"273","author":"DA Borrelli","year":"2018","unstructured":"Borrelli DA, Yankson K, Shukla N, Vilanilam G, Ticer T, Wolfram J. Extracellular vesicle therapeutics for liver disease. J Control Release. 2018;273:86\u201398.","journal-title":"J Control Release"},{"key":"2286_CR12","doi-asserted-by":"crossref","unstructured":"Cano A, Mu\u00f1oz-Morales \u00c1, S\u00e1nchez-L\u00f3pez E, Ettcheto M, Souto EB, Camins A et al. Exosomes-based nanomedicine for neurodegenerative diseases: current insights and future challenges. Pharmaceutics. 2023;15.","DOI":"10.3390\/pharmaceutics15010298"},{"key":"2286_CR13","doi-asserted-by":"publisher","first-page":"216151","DOI":"10.1016\/j.canlet.2023.216151","volume":"561","author":"J Garc\u00eda-Fern\u00e1ndez","year":"2023","unstructured":"Garc\u00eda-Fern\u00e1ndez J, Fuente Freire M. Exosome-like systems: nanotechnology to overcome challenges for targeted cancer therapies. Cancer Lett. 2023;561:216151.","journal-title":"Cancer Lett"},{"key":"2286_CR14","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1073\/pnas.1709210114","volume":"114","author":"M Wu","year":"2017","unstructured":"Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, Chen C, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017;114:10584\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.apsb.2021.08.016","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li Q, Liang Y, Zu M, Chen N, Canup BSB, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm Sin B. 2022;12:907\u201323.","journal-title":"Acta Pharm Sin B"},{"key":"2286_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","volume":"29","author":"HA Dad","year":"2021","unstructured":"Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther. 2021;29:13\u201331.","journal-title":"Mol Ther"},{"key":"2286_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12951-023-01919-x","volume":"21","author":"X Ou","year":"2023","unstructured":"Ou X, Wang H, Tie H, Liao J, Luo Y, Huang W, et al. Novel plant-derived exosome-like nanovesicles from catharanthus roseus: preparation, characterization, and immunostimulatory effect via TNF-\u03b1\/NF-\u03baB\/PU.1 axis. J Nanobiotechnol. 2023;21:160.","journal-title":"J Nanobiotechnol"},{"key":"2286_CR18","doi-asserted-by":"publisher","first-page":"100022","DOI":"10.1016\/j.plana.2022.100022","volume":"3","author":"D Subha","year":"2023","unstructured":"Subha D, Harshnii K, Madhikiruba K, Nandhini M, Tamilselvi KJPNB. Plant derived exosome-like nanovesicles: an updated overview. Plant Nano Biol. 2023;3:100022.","journal-title":"Plant Nano Biol"},{"key":"2286_CR19","doi-asserted-by":"publisher","first-page":"121178","DOI":"10.1016\/j.biomaterials.2021.121178","volume":"279","author":"M Zu","year":"2021","unstructured":"Zu M, Xie D, Canup BSB, Chen N, Wang Y, Sun R, et al. Green\u2019 nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases. Biomaterials. 2021;279:121178.","journal-title":"Biomaterials"},{"key":"2286_CR20","doi-asserted-by":"publisher","first-page":"28713","DOI":"10.3402\/jev.v4.28713","volume":"4","author":"X Zhuang","year":"2015","unstructured":"Zhuang X, Deng ZB, Mu J, Zhang L, Yan J, Miller D, et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage. J Extracell Vesicles. 2015;4:28713.","journal-title":"J Extracell Vesicles"},{"key":"2286_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2147\/IJN.S293067","volume":"16","author":"L Zhang","year":"2021","unstructured":"Zhang L, He F, Gao L, Cong M, Sun J, Xu J, et al. Engineering exosome-like nanovesicles derived from asparagus cochinchinensis can inhibit the proliferation of hepatocellular carcinoma cells with better safety profile. Int J Nanomedicine. 2021;16:1575\u201386.","journal-title":"Int J Nanomedicine"},{"key":"2286_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1082013207075602","volume":"13","author":"NMA Hassimotto","year":"2007","unstructured":"Hassimotto NMA, Genovese MI, Lajolo FMJFS. Identification and characterisation of anthocyanins from wild mulberry (Morus Nigra L.) growing in Brazil. Food Sci Technol Int. 2007;13:17\u201325.","journal-title":"Food Sci Technol Int"},{"key":"2286_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jpba.2007.03.031","volume":"44","author":"N Nuengchamnong","year":"2007","unstructured":"Nuengchamnong N, Ingkaninan K, Kaewruang W, Wongareonwanakij S, Hongthongdaeng B. Quantitative determination of 1-deoxynojirimycin in mulberry leaves using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2007;44:853\u20138.","journal-title":"J Pharm Biomed Anal"},{"key":"2286_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tifs.2008.06.002","volume":"19","author":"MS Butt","year":"2008","unstructured":"Butt MS, Nazir A, Sultan MT, Schro\u00ebn KJTFS. Morus alba L. nature\u2019s functional tonic. Trends Food Sci Technol. 2008;19:505\u201312.","journal-title":"Trends Food Sci Technol"},{"key":"2286_CR25","doi-asserted-by":"publisher","first-page":"e2203466","DOI":"10.1002\/smll.202203466","volume":"18","author":"Y Cao","year":"2022","unstructured":"Cao Y, Liu S, Ma Y, Ma L, Zu M, Sun J, et al. Oral nanomotor-enabled mucus traverse and tumor penetration for targeted chemo-sono-immunotherapy against colon cancer. Small. 2022;18:e2203466.","journal-title":"Small"},{"key":"2286_CR26","doi-asserted-by":"publisher","first-page":"121410","DOI":"10.1016\/j.biomaterials.2022.121410","volume":"282","author":"Y Ma","year":"2022","unstructured":"Ma Y, Duan L, Sun J, Gou S, Chen F, Liang Y, et al. Oral nanotherapeutics based on antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis. Biomaterials. 2022;282:121410.","journal-title":"Biomaterials"},{"key":"2286_CR27","doi-asserted-by":"publisher","first-page":"eaay4361","DOI":"10.1126\/sciadv.aay4361","volume":"6","author":"GS Hussey","year":"2020","unstructured":"Hussey GS, Pineda Molina C, Cramer MC, Tyurina YY, Tyurin VA, Lee YC, et al. Lipidomics and RNA sequencing reveal a novel subpopulation of nanovesicle within extracellular matrix biomaterials. Sci Adv. 2020;6:eaay4361.","journal-title":"Sci Adv"},{"key":"2286_CR28","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1166\/jnn.2015.9707","volume":"15","author":"H Zhang","year":"2015","unstructured":"Zhang H, Xiao Y, Cui S, Zhou Y, Zeng K, Yan M, et al. Novel galactosylated poly (ethylene glycol)-cholesterol for liposomes as a drug carrier for hepatocyte-targeting. J Nanosci Nanotechnol. 2015;15:4058\u201369.","journal-title":"J Nanosci Nanotechnol"},{"key":"2286_CR29","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1021\/acs.jafc.9b06931","volume":"68","author":"D Li","year":"2020","unstructured":"Li D, Chen G, Ma B, Zhong C, He N. Metabolic profiling and transcriptome analysis of mulberry leaves provide insights into flavonoid biosynthesis. J Agric Food Chem. 2020;68:1494\u2013504.","journal-title":"J Agric Food Chem"},{"key":"2286_CR30","doi-asserted-by":"publisher","first-page":"baaa011","DOI":"10.1093\/database\/baaa011","volume":"2020","author":"D Li","year":"2020","unstructured":"Li D, Ma B, Xu X, Chen G, Li T, He N. MMHub, a database for the mulberry metabolome. Database. 2020;2020:baaa011.","journal-title":"Database"},{"key":"2286_CR31","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He S, Tang S. WNT\/\u03b2-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.","journal-title":"Biomed Pharmacother"},{"key":"2286_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00784-012-0792-3","volume":"17","author":"PN Tawakoli","year":"2013","unstructured":"Tawakoli PN, Al-Ahmad A, Hoth-Hannig W, Hannig M, Hannig C. Comparison of different live\/dead stainings for detection and quantification of adherent microorganisms in the initial oral biofilm. Clin Oral Investig. 2013;17:841\u201350.","journal-title":"Clin Oral Investig"},{"key":"2286_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","volume":"87","author":"M Castaneda","year":"2022","unstructured":"Castaneda M, Den HP, Kuburich NA, Rosen JM, Mani SA. Mechanisms of cancer metastasis. Semin Cancer Biol. 2022;87:17\u201331.","journal-title":"Semin Cancer Biol"},{"key":"2286_CR34","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559\u201364.","journal-title":"Science"},{"key":"2286_CR35","doi-asserted-by":"crossref","unstructured":"Padhi S, Behera AJP. Cellular internalization and toxicity of polymeric nanoparticles. Polym Nanopart Treat Solid Tumors. 2022;473\u201388.","DOI":"10.1007\/978-3-031-14848-4_17"},{"key":"2286_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37:266.","journal-title":"J Exp Clin Cancer Res"},{"key":"2286_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1023\/A:1007486022411","volume":"14","author":"T Hirsch","year":"1998","unstructured":"Hirsch T, Susin SA, Marzo I, Marchetti P, Zamzami N. Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol. 1998;14:141\u20135.","journal-title":"Cell Biol Toxicol"},{"key":"2286_CR38","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","volume":"88","author":"ST Smiley","year":"1991","unstructured":"Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A. 1991;88:3671\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2286_CR39","doi-asserted-by":"crossref","unstructured":"Wang J, Sun J, Wang Y, Chou T, Zhang Q, Zhang B et al. Gold nanoframeworks with mesopores for raman-photoacoustic imaging and photo-chemo tumor therapy in the second near-infrared biowindow. Adv Funct Mater. 2020;30.","DOI":"10.1002\/adfm.201908825"},{"key":"2286_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","volume":"240","author":"A Date","year":"2016","unstructured":"Date A, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504\u201326.","journal-title":"J Control Release"},{"key":"2286_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557\u201370.","journal-title":"Adv Drug Deliv Rev"},{"key":"2286_CR42","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.addr.2016.04.014","volume":"106","author":"A Beloqui","year":"2016","unstructured":"Beloqui A, des Rieux A, Pr\u00e9at V. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier. Adv Drug Deliv Rev. 2016;106:242\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"2286_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","volume":"22","author":"D Compare","year":"2012","unstructured":"Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Carten\u00ec M, et al. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2012;22:471\u20136.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2286_CR44","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1007\/s00253-019-10211-8","volume":"103","author":"Q Wang","year":"2019","unstructured":"Wang Q, Lv L, Jiang H, Wang K, Yan R, Li Y, et al. Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. Appl Microbiol Biotechnol. 2019;103:9673\u201386.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2286_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12938\/bmfh.2020-046","volume":"40","author":"COM Jasirwan","year":"2021","unstructured":"Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I. Correlation of gut firmicutes\/bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci Microbiota Food Health. 2021;40:50\u20138.","journal-title":"Biosci Microbiota Food Health"},{"key":"2286_CR46","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3389\/fmicb.2019.01458","volume":"10","author":"J Ni","year":"2019","unstructured":"Ni J, Huang R, Zhou H, Xu X, Li Y, Cao P, et al. Analysis of the relationship between the degree of dysbiosis in gut microbiota and prognosis at different stages of primary hepatocellular carcinoma. Front Microbiol. 2019;10:1458.","journal-title":"Front Microbiol"},{"key":"2286_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jcmgh.2021.12.003","volume":"13","author":"FZ Xin","year":"2022","unstructured":"Xin FZ, Zhao ZH, Liu XL, Pan Q, Wang ZX, Zeng L, et al. Escherichia fergusonii promotes nonobese nonalcoholic fatty liver disease by interfering with host hepatic lipid metabolism through its own msRNA 23487. Cell Mol Gastroenterol Hepatol. 2022;13:827\u201341.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2286_CR48","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3748\/wjg.v21.i6.1691","volume":"21","author":"M Minemura","year":"2015","unstructured":"Minemura M, Shimizu Y. Gut microbiota and liver diseases. World J Gastroenterol. 2015;21:1691\u2013702.","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:05:18Z","timestamp":1704276318000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02286-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were approved by the Institutional Animal Care and Use Committee of Southwest University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and agreed to submit the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}